Viral CTLs

Phase 2Biologic

NNew York Medical College

Viral CTLs is one of 2 biologic programs targeting Cytomegalovirus (CMV). It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Cytomegalovirus (CMV)Recruiting

Cytomegalovirus (CMV)Phase 2

Recruiting

Competition

Competitive Landscape

2 competitors in Cytomegalovirus (CMV)

#DrugCompanyPhaseTrials

Viral CTLs

NNew York Medical College

Phase 2

1 2

VIR-1388

NNational Institute of Allergy and Infectious Diseases (NIAID)

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

Phase 2Recruiting

Cytomegalovirus (CMV)

NCT03266640

Q4 2032

Phase 3Recruiting

CMV

NCT07225972

Clinical

Trials by Indication[1]

Cytomegalovirus (CMV)1 trial

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

Recruiting·NNew York Medical College·Phase 2·NCT03266640·20 enrolled

CMV1 trial

An Open-Label Prospective Randomized Trial of Family Donor-Derived ADV or CMV CTLs Plus Standard of Care (SOC) vs SOC Alone in Children, Adolescents and Young Adults Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) With Refractory ADV or CMV Infection/Viremia

Recruiting·NNew York Medical College·Phase 3·NCT07225972·138 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Viral CTLs. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Viral CTLs compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Viral CTLs. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — New York Medical College company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Phase 2[1]
Company: NNew York Medical College

Viral CTLs

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Q4 2032

Trials by Indication[1]

Cytomegalovirus (CMV)1 trial

CMV1 trial

References

Drug Info

Quick Facts

Related News